ArticleUnited European gastroenterology journal2026
Clinical Validation of a Generative AI System for Diagnosing Ampullary Lesions: A Multicenter Study.
Article in United European gastroenterology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundAccurate histologic classification of ampullary lesions is essential for guiding therapeutic decisions; however, conventional biopsy is limited by sampling error and false-negative results. We evaluated the clinical utility of a generative artificial intelligence (AI)-based computer-aided diagnosis (CAD) system that integrates real and synthetic endoscopic images to improve diagnostic performance.
methodsIn this retrospective multicenter study conducted across seven hospitals, duodenoscopic images were classified as Normal, Adenoma, or Cancer. A generative AI-based CAD system using latent diffusion synthesized 500 images per class for data augmentation and was trained to predict histologic classes from endoscopic images. External validation assessed accuracy, sensitivity, specificity, positive and negative predictive values, and area under the receiver operating characteristic curve. A reader study involving five expert and five trainee endoscopists compared diagnostic performance with and without CAD assistance.
resultsThe generative AI-based CAD system demonstrated high overall diagnostic accuracy (91.57%) and strong performance in identifying adenomas (accuracy, 88.76%). In the reader study, CAD assistance significantly increased adenoma sensitivity (63.47%-70.56%; p < 0.01), with corresponding improvements in predictive values. Both expert and trainee endoscopists benefited from CAD support, with reduced interobserver variability and consistent improvements across Normal, Adenoma, and Cancer classifications.
conclusionsA generative AI-based CAD system improved diagnostic accuracy and consistency in the evaluation of ampullary lesions. These findings support its potential as a clinically useful adjunct to routine duodenoscopy, particularly for improving adenoma recognition and supporting therapeutic decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.